Increased p22phox/Nox4 expression is involved in remodeling through hydrogen peroxide signaling in experimental persistent pulmonary hypertension of the newborn

Antioxidants and Redox Signaling

Volumn 18, Issue 14, 2013, Pages 1765-1776

  Wedgwood, Stephen ^a   Lakshminrusimha, Satyan ^b   Czech, Lyubov ^a   Schumacker, Paul T ^a   Steinhorn, Robin H ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; EXTRACELLULAR SUPEROXIDE DISMUTASE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; P22 PHOX; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SMALL INTERFERING RNA; THIOL; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; DUCTUS ARTERIOSUS; INTRACELLULAR SIGNALING; LAMB; LUNG HOMOGENATE; NEWBORN; NONHUMAN; PERSISTENT PULMONARY HYPERTENSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY ARTERY; REVIEW; VASOCONSTRICTION;

ANIMALS; ANIMALS, NEWBORN; CYCLIN D1; DISEASE MODELS, ANIMAL; FLUORESCEINS; GENE EXPRESSION; HYDROGEN PEROXIDE; HYPERTENSION, PULMONARY; NADPH OXIDASE; NF-KAPPA B; PROLIFERATING CELL NUCLEAR ANTIGEN; PULMONARY ARTERY; RNA INTERFERENCE; SHEEP; SUPEROXIDE DISMUTASE;

OVIS ARIES;

EID: 84875109316     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4766     Document Type: Review

References (50)

1. Altenhofer S, Kleikers PW, Radermacher KA, Scheurer P, Rob Hermans JJ, Schiffers P, Ho H, Wingler K, and Schmidt HH. The NOX toolbox: validating the role of NADPH oxi-dases in physiology and disease. Cell Mol Life Sci 69: 2327-2343, 2012.
2. Ambasta R, Kumar P, Griendling K, Schmidt H, Busse R, and Brandes R. Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J Biol Chem 279: 45935-45941, 2004.
3. Aoyama T, Paik YH, Watanabe S, Laleu B, Gaggini F, Fior-aso-Cartier L, Molango S, Heitz F, Merlot C, Szyndralewiez C, Page P, and Brenner DA. Nicotinamide adenine dinu-cleotide phosphate oxidase (nox) in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent. Hepatology 56: 2316-2327.
4. Belik J, Pan J, Jankov R, and Tanswell A. Peroxynitrite inhibits relaxation and induces pulmonary artery muscle contraction in the newborn rat. Free Radic Biol Med 37: 1384-1392, 2004.
5. Black SM, Johengen MJ, and Soifer SJ. Coordinated regulation of genes of the nitric oxide and endothelin pathways during the development of pulmonary hypertension in fetal lambs. Pediatr Res 44: 821-830, 1998.
6. Bravo R and Macdonald-Bravo H. Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites. J Cell Biol 105: 1549-1554, 1987.
7. Brennan LA, Steinhorn RH, Wedgwood S, Mata-Greenwood E, Roark EA, Russell JA, and Black SM. Increased superox-ide generation is associated with pulmonary hypertension in fetal lambs: a role for NADPH oxidase. Circ Res 92: 683-691, 2003.
8. Cai H. NAD(P)H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease. Circ Res 96: 818-822, 2005.
9. Diebold I, Petry A, Hess J, and Görlach A. The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1. Mol Biol Cell 21: 2087-2096, 2010.
10. Dikalov S, Dikalova A, Bikineyeva A, Schmidt H, Harrison D, and Griendling K. Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production. Free Radic Biol Med 45: 1340-1351, 2008.
11. Dooley C, Dore T, Hanson G, Jackson W, Remington S, and Tsien R. Imaging dynamic redox changes in mammalian cells with green fluorescent protein indicators. J Biol Chem 279: 22284-22293, 2004.
12. Farrow K, Wedgwood S, Lee K, Czech L, Gugino S, Lakshminrusimha S, Schumacker P, and Steinhorn R. Mi-tochondrial oxidant stress increases PDE5 activity in persistent pulmonary hypertension of the newborn. Respir Physiol Neurobiol 174: 272-281, 2010.
13. Farrow KN, Groh BS, Schumacker PT, Lakshminrusimha S, Czech L, Gugino SF, Russell JA, and Steinhorn RH. Hyper-oxia increases phosphodiesterase 5 expression and activity in ovine fetal pulmonary artery smooth muscle cells. Circ Res 102: 226-233, 2008.
14. Farrow KN, Lakshminrusimha S, Reda WJ, Wedgwood S, Czech L, Gugino SF, Davis JM, Russell JA, and Steinhorn RH. Superoxide dismutase restores eNOS expression and function in resistance pulmonary arteries from neonatal lambs with persistent pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 295: L979-L987, 2008.
15. Guttridge D, Albanese C, Reuther J, Pestell R, and Baldwin AJ. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol 19: 5785-5799, 1999.
16. Hanson G, Aggeler R, Oglesbee D, Cannon M, Capaldi R, Tsien R, and Remington S. Investigating mitochondrial redox potential with redox-sensitive green fluorescent protein indicators. J Biol Chem 279: 13044-13053, 2004.
17. Haworth S. Pulmonary vascular remodeling in neonatal pulmonary hypertension. Chest 93: 133S-138S, 1988.
18. Heumüller S, Wind S, Barbosa-Sicard E, Schmidt H, Busse R, Schröder K, and Brandes R. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 51: 211-217, 2008.
19. Hink HU, Santanam N, Dikalov S, McCann L, Nguyen AD, Parthasarathy S, Harrison DG, and Fukai T. Peroxidase properties of extracellular superoxide dismutase: role of uric acid in modulating in vivo activity. Arterioscler Thromb Vasc Biol 22: 1402-1408, 2002.
20. Joyce D, Bouzahzah B, Fu M, Albanese C, D'Amico M, Steer J, Klein JU, Lee RJ, Segall JE, Westwick JK, Der CJ, and Pestell RG. Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-kappaB-dependent pathway. J Biol Chem 274: 25245-25249, 1999.
21. Jung O, Marklund S, Geiger H, Pedrazzini T, Busse R, and Brandes R. Extracellular superoxide dismutase is a major determinant of nitric oxide bioavailability: in vivo and ex vivo evidence from ecSOD-deficient mice. Circ Res 93: 622-629, 2003.
22. Kimura S, Egashira K, Chen L, Nakano K, Iwata E, Miya-gawa M, Tsujimoto H, Hara K, Morishita R, Sueishi K, To-minaga R, and Sunagawa K. Nanoparticle-mediated delivery of nuclear factor kappaB decoy into lungs ameliorates monocrotaline-induced pulmonary arterial hypertension. Hypertension 53: 877-883, 2009.
23. Lakshminrusimha S, Russell JA, Wedgwood S, Gugino SF, Kazzaz JA, Davis JM, and Steinhorn RH. Superoxide dis-mutase improves oxygenation and reduces oxidation in neonatal pulmonary hypertension. Am J Respir Crit Care Med 174: 1370-1377, 2006.
24. Lassegue B and Griendling KK. NADPH oxidases: functions and pathologies in the vasculature. Arterioscler Thromb Vasc Biol 30: 653-661, 2009.
25. Li W, Miller FJ, Zhang H, Spitz D, Oberley L, and Weintraub N. H(2)O(2)-induced O(2) production by a non-phagocytic NAD(P)H oxidase causes oxidant injury. J Biol Chem 276: 29251-29256, 2001.
26. Manea A, Manea S, Gafencu A, and Raicu M. Regulation of NADPH oxidase subunit p22(phox) by NF-kB in human aortic smooth muscle cells. Arch Physiol Biochem 113: 163-172, 2007.
27. Manea A, Manea S, Gafencu A, Raicu M, and Simionescu M. AP-1-dependent transcriptional regulation of NADPH oxidase in human aortic smooth muscle cells: role of p22phox subunit. Arterioscler Thromb Vasc Biol 28: 878-885, 2008.
28. Manea A, Tanase L, Raicu M, and Simionescu M. Tran-scriptional regulation of NADPH oxidase isoforms, Nox1 and Nox4, by nuclear factor-kappaB in human aortic smooth muscle cells. Biochem Biophy Res Commun 396: 901-907, 2010.
29. Marklund SL. Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species. Biochem J 222: 649-655, 1984.
30. Marklund SL. Properties of extracellular superoxide dis-mutase from human lung. Biochem J 220: 269-272, 1984.
31. Morin FC, 3rd. Ligating the ductus arteriosus before birth causes persistent pulmonary hypertension in the newborn lamb. Pediatr Res 25: 245-250, 1989.
32. Nisbet R, Graves A, Kleinhenz D, Rupnow H, Reed A, Fan T, Mitchell P, Sutliff R, and Hart C. The role of NADPH oxidase in chronic intermittent hypoxia-induced pulmonary hypertension in mice. Am J Respir Cell Mol Biol 40: 601-609, 2009.
33. Nozik-Grayck E, Suliman HB, and Piantadosi CA. Extracellular superoxide dismutase. Int J Biochem Cell Biol 37: 2466-2471, 2005.
34. Oury TD, Day BJ, and Crapo JD. Extracellular superoxide dismutase in vessels and airways of humans and baboons. Free Radic Biol Med 20: 957-965, 1996.
35. Sawada H, Mitani Y, Maruyama J, Jiang B, Ikeyama Y, Dida F, Yamamoto H, Imanka-Yoshida K, Shimpo H, Mizoguchi A, Maruyama K, and Komada Y. A nuclear factor-kappaB inhibitor pyrrolidine dithiocarbamate ameliorates pulmonary hypertension in rats. Chest 132: 1265-1274, 2007.
36. Serrander L, Cartier L, Bedard K, Banfi B, Lardy B, Plastre O, Sienkiewicz A, Forro L, Schlegel W, and Krause K. NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. Biochem J 406: 105-114, 2007.
37. Shaul PW, Yuhanna IS, German Z, Chen Z, Steinhorn RH, and Morin III FC. Pulmonary endothelial NO synthase gene expression is decreased in fetal lambs with pulmonary hypertension. Am J Physiol 272: L1005-L1012, 1997.
38. Sherr CJ. G1 phase progression: cycling on cue. Cell Metab 79: 551-555, 1994.
39. Steinhorn RH. Neonatal pulmonary hypertension. Pediatr Crit Care Med 11: S79-S84, 2010.
40. Stoimenov I and Helleday T. PCNA on the crossroad of cancer. Biochem Soc Trans 37: 605-613, 2009.
41. Traenckner E, Wilk S, and Baeuerle P. A proteasome inhibitor prevents activation of NF-{kappa}B and stabilizes a newly phosphorylated form of I{kappa}B-{alpha} that is still bound to NF-{kappa}B. EMBO J 15: 5433-5441, 1994.
42. Waypa G, Marks J, Guzy R, Mungai P, Schriewer J, Dokic D, and Schumacker P. Hypoxia triggers subcellular compart-mental redox signaling in vascular smooth muscle cells. Circ Res 106: 526-535, 2010.
43. Wedgwood S and Black SM. Induction of apoptosis in fetal pulmonary arterial smooth muscle cells by a combined su-peroxide dismutase/catalase mimetic. Am J Physiol Lung Cell Mol Physiol 285: L305-L312, 2003.
44. Wedgwood S and Black SM. Endothelin-1 decreases endo-thelial NOS expression and activity through ETA receptor-mediated generation of hydrogen peroxide. Am J Physiol Lung Cell Mol Physiol 288: L480-L487, 2005.
45. Wedgwood S, Dettman RW, and Black SM. ET-1 stimulates pulmonary arterial smooth muscle cell proliferation via induction of reactive oxygen species. Am J Physiol Lung Cell Mol Physiol 281: L1058-L1067, 2001.
46. Wedgwood S, Lakshminrusimha S, Farrow KN, Czech L, Gugino SF, Soares F, Russell JA, and Steinhorn RH. Apoc-ynin improves oxygenation and increases eNOS in persistent pulmonary hypertension of the newborn. Am J Physiol Lung Cell Mol Physiol 302: L616-L626, 2012.
47. Wedgwood S, Lakshminrusimha S, Fukai T, Russell JA, Schumacker PT, and Steinhorn RH. Hydrogen peroxide regulates extracellular superoxide dismutase activity and expression in neonatal pulmonary hypertension. Antioxid Redox Signal 15: 1497-1506, 2011.
48. Wedgwood S, Steinhorn RH, Bunderson M, Wilham J, Lakshminrusimha S, Brennan LA, and Black SM. Increased hydrogen peroxide downregulates soluble guanylate cyclase in the lungs of lambs with persistent pulmonary hypertension of the newborn. Am J Physiol Lung Cell Mol Physiol 289: L660-L666, 2005.
49. Wild LM, Nickerson PA, and Morin FC, 3rd. Ligating the ductus arteriosus before birth remodels the pulmonary vasculature of the lamb. Pediatr Res 25: 251-257, 1989.
50. Zayek M, Cleveland D, and Morin FC, 3rd. Treatment of persistent pulmonary hypertension in the newborn lamb by inhaled nitric oxide. J Pediatr 122: 743-750, 1993.